Comparison of Telavancin and Vancomycin for Complicated Skin and Skin Structure Infections With a Focus on Methicillin-resistant Staphylococcus Aureus

Clinical trial NCT00091819 · COMPLETED

Trial details

NCT number: NCT00091819
Sponsor: Cumberland Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Staphylococcal Skin Infection

Start date: 2005-01-01
Primary completion: 2006-06-01
Enrollment: 862

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.